These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. HL-A antibodies in chimpanzees after specific treatment with human leukocytes and antihuman lymphocyte globulin. Johannsen R; Seiler FR Transplant Proc; 1972 Mar; 4(1):77-81. PubMed ID: 5011649 [No Abstract] [Full Text] [Related]
27. Sharing Ia antigens between species. III. Ia specificities shared between mice and human beings. Lunney JK; Mann DL; Sachs DH Scand J Immunol; 1979; 10(5):403-13. PubMed ID: 94693 [TBL] [Abstract][Full Text] [Related]
29. Interaction of isoantibody and cytotoxic lymphocytes with allogeneic tumor cells. Faanes RB; Choi YS J Immunol; 1974 Jul; 113(1):279-88. PubMed ID: 4208919 [No Abstract] [Full Text] [Related]
30. Immunological aspects of human leukaemia. Viza D Ser Haematol; 1972; 5(5):87-108. PubMed ID: 4133766 [No Abstract] [Full Text] [Related]
31. New lymphocyte antigens controlled by the Ir-IgG region of the H-2 gene complex. David CS; Frelinger JA; Shreffler DC Transplantation; 1974 Jan; 17(1):122-5. PubMed ID: 4543678 [No Abstract] [Full Text] [Related]
32. [C4d]FlowPRA screening--a specific assay for selective detection of complement-activating anti-HLA alloantibodies. Wahrmann M; Exner M; Haidbauer B; Schillinger M; Regele H; Körmöczi G; Böhmig GA Hum Immunol; 2005 May; 66(5):526-34. PubMed ID: 15935890 [TBL] [Abstract][Full Text] [Related]
33. The identification of sera distinguishing marrow-derived and thymus-derived lymphocytes in the rat thoracic duct. Howard JC; Scott DW Immunology; 1974 Nov; 27(5):903-22. PubMed ID: 4611909 [TBL] [Abstract][Full Text] [Related]
34. Induction of I region-restricted hapten-specific cytotoxic T lymphocytes. Wagner H; Starzinski-Powitz A; Jung H; Röllinghoff M J Immunol; 1977 Oct; 119(4):1365-8. PubMed ID: 302282 [TBL] [Abstract][Full Text] [Related]
35. Leukocyte antigens of baboons. Downing HJ; Brain P; Hammond MG; Vos GH; Webb GR Transplant Proc; 1972 Mar; 4(1):33-6. PubMed ID: 4622179 [No Abstract] [Full Text] [Related]
36. Specific inhibition of HLA class I and II antibodies by soluble antigens--a method for the identification of antibody specificity in sera from alloimmunized individuals. Sumitran-Karuppan S; Möller E Transplantation; 1994 Sep; 58(6):713-9. PubMed ID: 7940692 [TBL] [Abstract][Full Text] [Related]
37. The cytotoxic reactivity and sialic acid content of human lymphoid cells. Reisner EG; Flye MW; Chung KS; Amos DB Tissue Antigens; 1974; 4(1):7-20. PubMed ID: 4545917 [No Abstract] [Full Text] [Related]
38. Studies of the antibodies against HLA, Ia-like, Fc, and/or C3 receptors present in pretransplant sera: anti-B-cell antibodies not associated with accelerated graft loss. Soulillou JP; Peyrat MA; Guenel J Transplant Proc; 1978 Jun; 10(2):475-7. PubMed ID: 354139 [No Abstract] [Full Text] [Related]
39. Tissue distribution of I region-associated antigens in the mouse. Hauptfeld V; Hauptfeld M; Klein J J Immunol; 1974 Jul; 113(1):181-8. PubMed ID: 4598886 [No Abstract] [Full Text] [Related]
40. Extraction and purification of soluble HL-A antigens from exhausted media of human lymphoid cell lines. Pellegrino MA; Pellegrino A; Ferrone S; Kahan BD; Reisfeld RA J Immunol; 1973 Sep; 111(3):783-8. PubMed ID: 4741297 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]